Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects

Detalhes bibliográficos
Autor(a) principal: Gopalswamy, Mohanraj
Data de Publicação: 2022
Outros Autores: Kroeger, Tobias, Bickel, David, Frieg, Benedikt, Akter, Shahina, Schott-Verdugo, Stephan, Viegas, Aldino, Pauly, Thomas, Mayer, Manuela, Przibilla, Julia, Reiners, Jens, Nagel-Steger, Luitgard, Smits, Sander H. J., Groth, Georg, Etzkorn, Manuel, Gohlke, Holger
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/150360
Resumo: Funding Information: This work was supported by a grant by the state of North-Rhine Westphalia and the European Fonds for Regional Development EFRE.NRW 2014-2020 to HG. We are grateful for computational support and infrastructure provided by the “Zentrum für Informations- und Medientechnologie” (ZIM) at the Heinrich Heine University Düsseldorf and the computing time provided by the John von Neumann Institute for Computing (NIC) to HG on the supercomputer JUWELS at Jülich Supercomputing Centre (JSC) (user ID: HKF7, VSK33). Financial support by Deutsche Forschungsgemeinschaft (DFG) through funds (INST 208/704-1 FUGG to HG) to purchase the hybrid computer cluster used in this study, an Emmy-Noether- and Heisenberg fellowship to ME (ET 103/2 and ET 103/5), and GRK 2158/2 (project number 270650915) to HG is gratefully acknowledged. Publisher Copyright: © 2022, The Author(s).
id RCAP_5c96578530150d3f0fe6f48027ce1eff
oai_identifier_str oai:run.unl.pt:10362/150360
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effectsGeneralSDG 3 - Good Health and Well-beingFunding Information: This work was supported by a grant by the state of North-Rhine Westphalia and the European Fonds for Regional Development EFRE.NRW 2014-2020 to HG. We are grateful for computational support and infrastructure provided by the “Zentrum für Informations- und Medientechnologie” (ZIM) at the Heinrich Heine University Düsseldorf and the computing time provided by the John von Neumann Institute for Computing (NIC) to HG on the supercomputer JUWELS at Jülich Supercomputing Centre (JSC) (user ID: HKF7, VSK33). Financial support by Deutsche Forschungsgemeinschaft (DFG) through funds (INST 208/704-1 FUGG to HG) to purchase the hybrid computer cluster used in this study, an Emmy-Noether- and Heisenberg fellowship to ME (ET 103/2 and ET 103/5), and GRK 2158/2 (project number 270650915) to HG is gratefully acknowledged. Publisher Copyright: © 2022, The Author(s).Acute myeloid leukemia (AML) is a malignant disease of immature myeloid cells and the most prevalent acute leukemia among adults. The oncogenic homo-tetrameric fusion protein RUNX1/ETO results from the chromosomal translocation t(8;21) and is found in AML patients. The nervy homology region 2 (NHR2) domain of ETO mediates tetramerization; this oligomerization is essential for oncogenic activity. Previously, we identified the first-in-class small-molecule inhibitor of NHR2 tetramer formation, 7.44, which was shown to specifically interfere with NHR2, restore gene expression down-regulated by RUNX1/ETO, inhibit the proliferation of RUNX1/ETO-depending SKNO-1 cells, and reduce the RUNX1/ETO-related tumor growth in a mouse model. However, no biophysical and structural characterization of 7.44 binding to the NHR2 domain has been reported. Likewise, the compound has not been characterized as to physicochemical, pharmacokinetic, and toxicological properties. Here, we characterize the interaction between the NHR2 domain of RUNX1/ETO and 7.44 by biophysical assays and show that 7.44 interferes with NHR2 tetramer stability and leads to an increase in the dimer population of NHR2. The affinity of 7.44 with respect to binding to NHR2 is Klig = 3.75 ± 1.22 µM. By NMR spectroscopy combined with molecular dynamics simulations, we show that 7.44 binds with both heteroaromatic moieties to NHR2 and interacts with or leads to conformational changes in the N-termini of the NHR2 tetramer. Finally, we demonstrate that 7.44 has favorable physicochemical, pharmacokinetic, and toxicological properties. Together with biochemical, cellular, and in vivo assessments, the results reveal 7.44 as a lead for further optimization towards targeted therapy of t(8;21) AML.UCIBIO - Applied Molecular Biosciences UnitDQ - Departamento de QuímicaRUNGopalswamy, MohanrajKroeger, TobiasBickel, DavidFrieg, BenediktAkter, ShahinaSchott-Verdugo, StephanViegas, AldinoPauly, ThomasMayer, ManuelaPrzibilla, JuliaReiners, JensNagel-Steger, LuitgardSmits, Sander H. J.Groth, GeorgEtzkorn, ManuelGohlke, Holger2023-03-10T22:54:28Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article18application/pdfhttp://hdl.handle.net/10362/150360eng2045-2322PURE: 55275172https://doi.org/10.1038/s41598-022-17913-6info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:32:20Zoai:run.unl.pt:10362/150360Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:54:04.441306Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
title Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
spellingShingle Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
Gopalswamy, Mohanraj
General
SDG 3 - Good Health and Well-being
title_short Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
title_full Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
title_fullStr Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
title_full_unstemmed Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
title_sort Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
author Gopalswamy, Mohanraj
author_facet Gopalswamy, Mohanraj
Kroeger, Tobias
Bickel, David
Frieg, Benedikt
Akter, Shahina
Schott-Verdugo, Stephan
Viegas, Aldino
Pauly, Thomas
Mayer, Manuela
Przibilla, Julia
Reiners, Jens
Nagel-Steger, Luitgard
Smits, Sander H. J.
Groth, Georg
Etzkorn, Manuel
Gohlke, Holger
author_role author
author2 Kroeger, Tobias
Bickel, David
Frieg, Benedikt
Akter, Shahina
Schott-Verdugo, Stephan
Viegas, Aldino
Pauly, Thomas
Mayer, Manuela
Przibilla, Julia
Reiners, Jens
Nagel-Steger, Luitgard
Smits, Sander H. J.
Groth, Georg
Etzkorn, Manuel
Gohlke, Holger
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv UCIBIO - Applied Molecular Biosciences Unit
DQ - Departamento de Química
RUN
dc.contributor.author.fl_str_mv Gopalswamy, Mohanraj
Kroeger, Tobias
Bickel, David
Frieg, Benedikt
Akter, Shahina
Schott-Verdugo, Stephan
Viegas, Aldino
Pauly, Thomas
Mayer, Manuela
Przibilla, Julia
Reiners, Jens
Nagel-Steger, Luitgard
Smits, Sander H. J.
Groth, Georg
Etzkorn, Manuel
Gohlke, Holger
dc.subject.por.fl_str_mv General
SDG 3 - Good Health and Well-being
topic General
SDG 3 - Good Health and Well-being
description Funding Information: This work was supported by a grant by the state of North-Rhine Westphalia and the European Fonds for Regional Development EFRE.NRW 2014-2020 to HG. We are grateful for computational support and infrastructure provided by the “Zentrum für Informations- und Medientechnologie” (ZIM) at the Heinrich Heine University Düsseldorf and the computing time provided by the John von Neumann Institute for Computing (NIC) to HG on the supercomputer JUWELS at Jülich Supercomputing Centre (JSC) (user ID: HKF7, VSK33). Financial support by Deutsche Forschungsgemeinschaft (DFG) through funds (INST 208/704-1 FUGG to HG) to purchase the hybrid computer cluster used in this study, an Emmy-Noether- and Heisenberg fellowship to ME (ET 103/2 and ET 103/5), and GRK 2158/2 (project number 270650915) to HG is gratefully acknowledged. Publisher Copyright: © 2022, The Author(s).
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01T00:00:00Z
2023-03-10T22:54:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/150360
url http://hdl.handle.net/10362/150360
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2045-2322
PURE: 55275172
https://doi.org/10.1038/s41598-022-17913-6
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 18
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138130529353728